Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Cancel Anytime
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99per week for the first 24weeks
Just $1.99per week for the first 24weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

International Development Minister Karina Gould responds during question period in the House of Commons, in Ottawa, on Dec. 10, 2019.

Adrian Wyld/The Canadian Press

Canada’s foreign-aid budget swelled noticeably Monday with International Development Minister Karina Gould’s announcement of $485-million in new money toward the global effort to provide COVID-19 medicines to poor countries.

The new funds are going towards the Access to COVID-19 Tools, or “ACT” Accelerator, which was created in April by the World Health Organization, the French government, the European Commission and the Bill and Melinda Gates Foundation.

Gould and Procurement Minister Anita Anand also left open the possibility Monday that if Canada has any surpluses of vaccines it has already pre-bought, they could be shared with poorer countries.

Story continues below advertisement

Gould said that with only one vaccine currently approved by Health Canada, it’s too early to make that determination.

“We are part of a global community, and our health at home depends on the health of everyone everywhere. Canadians understand that no one is safe from COVID-19 unless everyone is safe, and today’s new commitments will help to make that possible,” said Gould.

Anand said Gould’s announcement “is a promise to help other countries when we will be able to do so.”

What we know about Pfizer's coronavirus vaccine, Canada's immunization plans, and more. Join science reporter Ivan Semeniuk and health reporter Kelly Grant for a Q&A on Facebook live on Tues., Dec. 15 at 1:00 p.m. ET

Canada has secured guarantees for 214 million doses of vaccine, if all seven vaccine candidates procured are approved. It has also negotiated the potential to get another 200 million doses.

Last week, Oxfam Canada released a report that said Canada topped the list of rich countries that have pre-bought COVID-19 vaccines, having secured enough to cover its population five times over. Oxfam urged Canadians to show more compassion to poorer people.

On Monday, Oxfam Canada’s interim executive director Kate Higgins said the organization was “pleased to see Canada take additional and ongoing leadership to ensure that everyone on the planet has access to the COVID-19 vaccine.”

Higgins also said that “the only way we will get vaccines for everyone is for pharmaceutical corporations to openly share their technology and intellectual property. We hope Canada will continue to push for this as well.”

Story continues below advertisement

The advocacy group One Campaign, which has criticized Canada’s relatively low foreign aid spending in the past, offered effusive praise.

Stuart Hickox, the Canada director for One Campaign, said the announcement marked a “great day” for Canada.

“As COVID vaccinations begin here, Canada is also showing global leadership in the fight to end the pandemic everywhere. Today’s investment is Canadian compassion in action. It’s also smart,” he said, saying that every $1 spent on aid would generate a $5.60 return to Canada’s economy.

Michael Messenger, president of World Vision Canada, said where a child is born shouldn’t have an impact on whether they get access to a life-saving vaccine.

“It’s a human right,” he said.

“This commitment will help to make sure that girls and boys living in the most fragile parts of the world benefit from the great work of some of the smartest people and latest technology. This is how we will end this pandemic together.”

Story continues below advertisement

The ACT Accelerator is part of a global effort to ensure low– and middle-income countries have equitable access to medical treatments during the pandemic.

It supports organizations, health professionals and businesses in their efforts to develop vaccines, as well as drug therapies and diagnostic tools to battle the pandemic.

Monday’s announcement includes $255-million in additional support for the ACT Accelerator through “focused investments” in the World Health Organization, the Pan-American Health Organization, the Coalition for Epidemic Preparedness Innovations (CEPI) and Gavi, the Vaccine Alliance, which distributes vaccines in poor countries.

Canada has now committed more than $865-million to the ACT-Accelerator and has also pledged $220-million to its partner initiative, the COVAX Facility, to help buy vaccine doses for low– and middle-income countries.

A spokesman for Gould said that based on the government’s latest annual spending figures for the fiscal year of 2018-2019, Canada delivered $5.9-billion in official development assistance.

Science reporter Ivan Semeniuk outlines how Canada benefited from researchers working in parallel and accelerated the approval process to have a safe COVID-19 vaccine ready so quickly.

Sign up for the Coronavirus Update newsletter to read the day’s essential coronavirus news, features and explainers written by Globe reporters and editors.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies